ImmunoCellular, Torrey Pines Institute for Molecular Studies deal

The partners expanded their 2009 deal to identify peptides targeting Prominin 1 ( PROM1; CD133). Under the expanded agreement, the partners will identify peptides against the numb and notch pathways...